全文获取类型
收费全文 | 1017篇 |
免费 | 85篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 27篇 |
妇产科学 | 18篇 |
基础医学 | 186篇 |
口腔科学 | 27篇 |
临床医学 | 51篇 |
内科学 | 166篇 |
皮肤病学 | 19篇 |
神经病学 | 36篇 |
特种医学 | 22篇 |
外国民族医学 | 1篇 |
外科学 | 168篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 75篇 |
眼科学 | 7篇 |
药学 | 95篇 |
中国医学 | 13篇 |
肿瘤学 | 160篇 |
出版年
2024年 | 3篇 |
2023年 | 6篇 |
2022年 | 28篇 |
2021年 | 45篇 |
2020年 | 25篇 |
2019年 | 35篇 |
2018年 | 53篇 |
2017年 | 35篇 |
2016年 | 45篇 |
2015年 | 32篇 |
2014年 | 51篇 |
2013年 | 67篇 |
2012年 | 74篇 |
2011年 | 70篇 |
2010年 | 43篇 |
2009年 | 44篇 |
2008年 | 63篇 |
2007年 | 59篇 |
2006年 | 62篇 |
2005年 | 47篇 |
2004年 | 46篇 |
2003年 | 33篇 |
2002年 | 34篇 |
2001年 | 13篇 |
2000年 | 14篇 |
1999年 | 8篇 |
1998年 | 9篇 |
1997年 | 9篇 |
1996年 | 6篇 |
1995年 | 6篇 |
1994年 | 3篇 |
1993年 | 4篇 |
1992年 | 5篇 |
1991年 | 6篇 |
1990年 | 4篇 |
1989年 | 2篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1978年 | 1篇 |
1975年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1969年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有1104条查询结果,搜索用时 15 毫秒
991.
Anne R Simoneau Eugene W Gerner Ray Nagle Argyrios Ziogas Sharon Fujikawa-Brooks Hagit Yerushalmi Thomas E Ahlering Ronald Lieberman Christine E McLaren Hoda Anton-Culver Frank L Meyskens 《Cancer epidemiology, biomarkers & prevention》2008,17(2):292-299
BACKGROUND: Prostate cancer is a major health issue, and prevention of prostate cancer and/or its progression will yield benefits for men. Difluoromethylornithine (DFMO) is an antiproliferative agent, inhibiting ornithine decarboxylase, the first enzyme in the polyamine pathway, and has been studied as a therapeutic and chemopreventive agent. The prostate has high levels of tissue polyamines and has shown sensitivity to DFMO both in vitro and in vivo. METHODS: Eighty-one men participated in a 1-year randomized trial of placebo or DFMO. Prostate volume determination and biopsy of the prostate for histology and polyamine content were done at baseline and after 12 months. Other biomarker variables were assessed, including total and free prostate-specific antigen and prostate-specific antigen doubling time. RESULTS: Compared with baseline, men receiving DFMO had a smaller increase in prostate volume (0.14 cm(3)) than those on placebo (2.95 cm(3); P = 0.0301) at 1 year. In addition, DFMO caused a 60.8% reduction of prostate putrescine levels compared with a 139.5% increase in the placebo arm (P = 0.0014). Stratification by ornithine decarboxylase genotype showed that DFMO reduced prostate volume (P = 0.029) and putrescine levels (P = 0.0053) in the AA + GA group but not in the GG group. There were no grade 3 or 4 toxicities. There was no clinical ototoxicity, with one subclinical grade 2 hearing decline on audiogram. CONCLUSION: In this randomized placebo-controlled trial, DFMO induced a decrease of prostate putrescine levels and rate of prostate growth. The potential of this compound for prostate cancer or hyperplasia should be further studied. 相似文献
992.
993.
Erin E. Kent Leonard S. Sender Joan A. Largent Hoda Anton-Culver 《Cancer causes & control : CCC》2009,20(8):1409-1420
Objective
In California, leukemia represents ~35, 5, and 2% of all cancers in children (aged 0–14), adolescents (15–29), and young adults (30–39), respectively. Poorer survival has been previously noted in individuals residing in lower socioeconomic status (SES) neighborhoods. We explored the relationship between SES and survival as modified by age and race/ethnicity using data from the California Cancer Registry. 相似文献994.
Fatemeh Kolangi Hamid Shafi Zahra Memariani Mohammad Kamalinejad Soodabeh Bioos Seyed Gholam Ali Jorsaraei Ali Bijani Hoda Shirafkan Seyyed Ali Mozaffarpur 《Andrologia》2019,51(1)
Despite scientific advances, many of the treatments in male infertility remained indeterminate. In recent years, the attention to herbal remedies as an effective treatment for male infertility is considerable. We designed this study to determine the effects of Alpinia officinarum on the results of semen analysis in men with idiopathic infertility. In this clinical trial, seventy‐six participants with idiopathic infertility were included in the intervention (plant treatment: n = 31; placebo: n = 29). Participants were randomised to take capsules containing dried extract of A. officinarum rhizome or placebo on a daily (total daily dosage of 300 mg) basis for 3 months. After 12 weeks of intervention, the sperm count and total number of spermatozoa with normal morphology were increased in participants treated with A. officinarum extract compared with the placebo group. The mean sperm count was initially 52 × 106 ± 24 × 106/ml which changed to 71 × 106 ± 23 × 106/ml, after intervention (p = 0.043). Also, the mean percentage of spermatozoa with normal morphology was 14.34% ± 9.16% before the treatment which significantly increased to 19% ± 14.89% (p < 0.001). Alpinia officinarum, a traditional medicine remedy, can be effective in the improvement of sperm morphology and sperm count in idiopathic infertility without causing adverse effects. 相似文献
995.
Women’s sexual dysfunction after breast cancer diagnosis and treatment has received little research attention in Iran (I.R).
Our goal was to identify sexual dysfunction and its related factors in Iranian women after diagnosis of breast cancer. A sample
of 82 female breast cancer survivors seen for routine follow-up appointment from March 2006 to March 2007 completed a survey
questionnaire regarding their sexual experiences, body image perception and opinion about sex after cancer diagnosis and treatment.
The various aspects of sexual function that were disturbed was related to factors such as age, marital status, body image
perception, and perceived husband’s attitude. The authors conclude that healthcare workers’ education is very important, so
taking time to do research and passing along knowledge will go a long way in helping to address sexual disturbances in breast
cancer survivor in our community. 相似文献
996.
Genome Degradation in Brucella ovis Corresponds with Narrowing of Its Host Range and Tissue Tropism 下载免费PDF全文
Renee M. Tsolis Rekha Seshadri Renato L. Santos Felix J. Sangari Juan M. García Lobo Maarten F. de Jong Qinghu Ren Garry Myers Lauren M. Brinkac William C. Nelson Robert T. DeBoy Samuel Angiuoli Hoda Khouri George Dimitrov Jeffrey R. Robinson Stephanie Mulligan Richard L. Walker Philip E. Elzer Karl A. Hassan Ian T. Paulsen 《PLoS Clinical Trials》2009,4(5)
Brucella ovis is a veterinary pathogen associated with epididymitis in sheep. Despite its genetic similarity to the zoonotic pathogens B. abortus, B. melitensis and B. suis, B. ovis does not cause zoonotic disease. Genomic analysis of the type strain ATCC25840 revealed a high percentage of pseudogenes and increased numbers of transposable elements compared to the zoonotic Brucella species, suggesting that genome degradation has occurred concomitant with narrowing of the host range of B. ovis. The absence of genomic island 2, encoding functions required for lipopolysaccharide biosynthesis, as well as inactivation of genes encoding urease, nutrient uptake and utilization, and outer membrane proteins may be factors contributing to the avirulence of B. ovis for humans. A 26.5 kb region of B. ovis ATCC25840 Chromosome II was absent from all the sequenced human pathogenic Brucella genomes, but was present in all of 17 B. ovis isolates tested and in three B. ceti isolates, suggesting that this DNA region may be of use for differentiating B. ovis from other Brucella spp. This is the first genomic analysis of a non-zoonotic Brucella species. The results suggest that inactivation of genes involved in nutrient acquisition and utilization, cell envelope structure and urease may have played a role in narrowing of the tissue tropism and host range of B. ovis. 相似文献
997.
McEligot AJ Im T Dillman RO West JG Salem R Haque R Anton-Culver H 《Cancer causes & control : CCC》2008,19(10):1217-1226
Cancer registries routinely collect data on clinicopathologic factors, but rarely abstract anthropometric variables. We conducted
a chart review study, examining the feasibility of abstracting weight, height, alcohol use, and smoking from medical records
in women (n = 1,974) diagnosed with invasive breast cancer, and investigated the association between the abstracted variables with clinicopathologic
features. Qualitative data were reviewed and categorized. Frequencies of the abstracted data, and demographic and clinicopathologic
variables were calculated. Logistic regression models measured the relationship between the outcome variables, tumor size,
stage of disease, and estrogen/progesterone (ER/PR) status with the abstracted variables. Data on current alcohol-use/no-use,
current-smoker/non-smoker, and height/weight data were obtained on 96%, 97%, and 88–89% of the participants, respectively.
The multivariate analysis showed that overweight (≥25 kg/m2) women had significantly larger (≥2 cm) tumor size compared with normal weight for both women <50 years (OR = 1.79; 95% CI = 1.14–2.81;
p ≤ 0.05) and for women ≥50 years at diagnosis (OR = 1.58; 95% CI = 1.19–2.09; p ≤ 0.05). These results suggest that abstracting current height and weight via medical records is feasible, and at minimum,
current alcohol use and smoking status can be ascertained. In addition, being overweight was significantly associated with
cancer clinicopathologic/prognostic factors, which has implications for monitoring etiologic factors that could be associated
with cancer trends, incidence, and survival. Therefore routine collection of height and weight via cancer registries should
be explored further. 相似文献
998.
999.
Hoda Y. Tomoum Gehan A. Mostafa and Esraa M. F. El-Shahat 《Pediatrics international》2009,51(2):188-192
Background: Objective biomarkers are needed for early diagnosis of juvenile idiopathic arthritis (JIA). Anti-A33 antibodies are considered good markers for adult rheumatoid arthritis (RA), but little information is available on their occurrence in JIA. The aim of the present study was therefore to investigate the value of anti-RA33 for diagnosis of JIA (both early and established disease), and its relation to markers of disease activity, and bone resorption.
Subjects: This case–control study was conducted on 34 children with JIA. Ten patients with arthritis of short duration (<6 weeks) were included, as undifferentiated arthritis. Forty-four age- and sex- matched healthy children served as controls. Beside evaluation and assessment of disease activity, urinary calcium, serum parathyroid hormone and serum anti-RA33 were measured in included subjects. Joints were examined radiologically and modified Larsen index (LI) was estimated.
Results: During follow up, eight of the patients with undifferentiated arthritis were diagnosed as having early JIA. Patients with JIA (early and established cases) had higher anti-RA33 levels than the control group (z = 6.04, 3.95, respectively). A total of 66.7% of the patients were positive for anti-RA33, results were comparable in early and established cases. Anti-RA33 values were correlated to disease activity (clinical and laboratory), to laboratory markers (urinary calcium, parathyroid hormone levels) and radiological evidence (LI) of bone resorption ( r = 0.95, 0.63, 0.94, respectively).
Conclusion: Anti-RA33 is detected in two-thirds of JIA patients and occurs with comparable frequency early in the disease. Its levels are correlated to disease activity and markers of bone resorption and it seems to convey diagnostic and prognostic insights for appropriate management. 相似文献
Subjects: This case–control study was conducted on 34 children with JIA. Ten patients with arthritis of short duration (<6 weeks) were included, as undifferentiated arthritis. Forty-four age- and sex- matched healthy children served as controls. Beside evaluation and assessment of disease activity, urinary calcium, serum parathyroid hormone and serum anti-RA33 were measured in included subjects. Joints were examined radiologically and modified Larsen index (LI) was estimated.
Results: During follow up, eight of the patients with undifferentiated arthritis were diagnosed as having early JIA. Patients with JIA (early and established cases) had higher anti-RA33 levels than the control group (z = 6.04, 3.95, respectively). A total of 66.7% of the patients were positive for anti-RA33, results were comparable in early and established cases. Anti-RA33 values were correlated to disease activity (clinical and laboratory), to laboratory markers (urinary calcium, parathyroid hormone levels) and radiological evidence (LI) of bone resorption ( r = 0.95, 0.63, 0.94, respectively).
Conclusion: Anti-RA33 is detected in two-thirds of JIA patients and occurs with comparable frequency early in the disease. Its levels are correlated to disease activity and markers of bone resorption and it seems to convey diagnostic and prognostic insights for appropriate management. 相似文献
1000.
Sharon Manne Hoda Badr Talia Zaider Christian Nelson David Kissane 《Journal of cancer survivorship》2010,4(1):74-85